Sort
10,766 grants matching “checkpoint inhibitor”
Hi-jacking the kynurenine pathway: A new therapeutic approach used to treat cisplatin resistant lung cancer that evades immune surveillance and proliferates with increased ROS levels
$0Medhi Wangpaichitr · Miami Va Health Care System · I01 · FY2025 · VA
Autoinflammation in Human Melanoma
$0Mayumi Fujita · Va Eastern Colorado Health Care System · I01 · FY2022 · VA
IL-1-based immunotherapy in HNSCC
$0Andrean Llewela Burnett · Iowa City Va Medical Center · I01 · FY2025 · VA
Stratification of Pancreatic Cancer Subpopulations for Effective Immunotherapy
$0Qizhi C. Yao · Michael E Debakey Va Medical Center · I01 · FY2020 · VA
Clinically Actionable Neoantigens in Non-Small Cell Lung Cancer
$0Steven M. Dubinett · Va Greater Los Angeles Healthcare System · I01 · FY2020 · VA
Combining Immune Therapy with Targeted Therapies to Improve Melanoma Survival
$0Ann Richmond · Veterans Health Administration · I01 · FY2022 · VA
Role of ATRX, a chromatin remodeler, in immunotherapy response
$0Daniel Sanghoon Shin · Va Greater Los Angeles Healthcare System · I01 · FY2022 · VA
Improving Treatment Algorithms for Veterans with Oropharyngeal Cancer
$0Vlad C Sandulache · Michael E Debakey Va Medical Center · IK2 · FY2021 · VA
A Phase 2 study of a Checkpoint Inhibitor in Men with Progressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation
$0Matthew B Rettig · Va Greater Los Angeles Healthcare System · I01 · FY2020 · VA
BLRD Merit Review Research Career Scientist (RCS) Award (IK6)
$0Jin Chen · Veterans Health Administration · IK6 · FY2021 · VA
Role of ATRX, a chromatin remodeler, in immunotherapy response
$0Daniel Sanghoon Shin · Va Greater Los Angeles Healthcare System · I01 · FY2023 · VA
Type I Interferon Regulation of PD-L1 Expression and Function in MDSCs
$0Kebin Liu · Charlie Norwood Va Medical Center · I01 · FY2020 · VA
The role of eosinophils and oxidative stress in esophageal malignancy
$0Yash Choksi · Veterans Health Administration · IK2 · FY2022 · VA
DC-HIL in cancer
$0Ponciano D Cruz · Va North Texas Health Care System · I01 · FY2020 · VA
Mechanisms of Response to Reflux-Induced Oxidative Stress in Barrett's Esophagus
$0Kerry Brandt Dunbar · Va North Texas Health Care System · I01 · FY2018 · VA
Muscarinic Receptors Regulate Colon Cancer Stem Cell Function and Invasiveness
$0Jean-Pierre Raufman · Baltimore Va Medical Center · I01 · FY2022 · VA
Building a New Therapeutic Paradigm for Hepatocellular Cancer by Dissecting the Interaction between Radiofrequency Ablation, Chemotherapy, and Immunotherapy
$0Eric T. Kimchi · Harry S. Truman Memorial Va Hospital · I01 · FY2022 · VA
Antiproliferative Effects Of Small Molecules: Basic And
$0Dental &Craniofacial Research · Z01 · FY2002 · DE
To Elucidate the Biological Function and Translational Potential of NLRP3 in Immunotherapy-resistant Melanoma
$0Carlo Marchetti · Va Eastern Colorado Health Care System · IK2 · FY2025 · VA
The Molecular Mechanism Of Cell Cycle Regulation In Budd
$0Diabetes, Digestive, Kidney Diseases · Z01 · FY2004 · DK
Cell Cycle Regulation In Oogenesis
$0Child Health And Human Development · Z01 · FY2004 · HD
Targeting Integrins in Lung Cancer
$0Tianhong Li · Va Northern California Health Care Sys · I01 · FY2021 · VA
Improving Treatment Algorithms for Veterans with Oropharyngeal Cancer
$0Vlad C Sandulache · Michael E Debakey Va Medical Center · IK2 · FY2020 · VA
Genome Instability in Cancer Development
$0Kyungjae Myung · Human Genome Research · Z01 · FY2006 · HG
The Molecular Mechanism Of Cell Cycle Regulation In Budd
$0Diabetes, Digestive, Kidney Diseases · Z01 · FY2002 · DK